MAPT and Alzheimer disease: There was no reduction in Aβ42 or the other measured Aβ fragments despite the reduction in sAPPβ, nor was there a distinct elevation of p-tau in any of the HIV-infected groups, including HAD, consistent with other evidence that HAD brain injury is very different from that of Alzheimer's disease.